Research Article
Evaluation of MGIT 960 System for the Second-Line Drugs Susceptibility Testing of Mycobacterium tuberculosis
Table 1
Clinical M. tuberculosis strains used in the study.
| Test drugs | Number of strains | Susceptible | Resistanta |
| MXF | | | New cases | 37 | 4 | Previously treated cases | 3 | 15 | LEV | | | New cases | 40 | 4 | Previously treated cases | 0 | 15 | KM | | | New cases | 40 | 6 | Previously treated cases | 0 | 10 | CPM | | | New cases | 39 | 5 | Previously treated cases | 1 | 6 | ETH | | | New cases | 39 | 2 | Previously treated cases | 0 | 6 | PAS | | | New cases | 40 | 6 | Previously treated cases | 0 | 11 |
|
|
Treatment period of drug in resistant strains was >6 months.
|